[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Survey and Trend Research 2018

May 2018 | 76 pages | ID: G112AEE6B07EN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Glaxo Smith Kline, Johnson & Johnson, Bayer, Novacap, Pfizer, Pfizer, Geri-Care Pharmaceuticals, Perrigo Company, Kopran, Merck Sharp & Dohme, Sun Pharmaceutical Industries, Reddy Pharmaceuticals etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAID) MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

PART 4 KEY COMPANIES LIST

4.1 Glaxo Smith Kline (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Johnson & Johnson (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Bayer (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Novacap (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Pfizer (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Pfizer (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Geri-Care Pharmaceuticals (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Perrigo Company (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Kopran (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Merck Sharp & Dohme (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Sun Pharmaceutical Industries (Company Overview, Sales Data etc.)
4.12 Reddy Pharmaceuticals (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2012-2017, by Type, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2012-2017, by Type, in Volume
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2018-2023, by Type, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2018-2023, by Type, in Volume
Table Glaxo Smith Kline Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Glaxo Smith Kline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novacap Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Novacap (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Geri-Care Pharmaceuticals Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Geri-Care Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Perrigo Company Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Perrigo Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kopran Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Kopran (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Sharp & Dohme Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Merck Sharp & Dohme (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sun Pharmaceutical Industries Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Reddy Pharmaceuticals Overview List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Business Operation of Reddy Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Revenue Share, by Companies, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume 2012-2017, by Companies, in Volume
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Revenue Share, by Companies in 2017, in Volume
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Demand 2012-2017, by Application, in USD Million
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Demand 2012-2017, by Application, in Volume
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Demand Forecast 2018-2023, by Application, in USD Million
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Demand Forecast 2018-2023, by Application, in Volume
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2012-2017, by Region, in USD Million
Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market 2012-2017, by Region, in Volume
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2018-2023, by Region, in USD Million
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast 2018-2023, by Region, in Volume

LIST OF FIGURES

Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Chain Structure
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2012-2017, by Type, in USD Million
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Growth 2012-2017, by Type, in Volume
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region


More Publications